Format

Send to

Choose Destination
See comment in PubMed Commons below
Iran J Microbiol. 2012 Jun;4(2):47-54.

Molecular beacon probes-base multiplex NASBA Real-time for detection of HIV-1 and HCV.

Author information

1
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

Abstract

BACKGROUND AND OBJECTIVES:

Developed in 1991, nucleic acid sequence-based amplification (NASBA) has been introduced as a rapid molecular diagnostic technique, where it has been shown to give quicker results than PCR, and it can also be more sensitive. This paper describes the development of a molecular beacon-based multiplex NASBA assay for simultaneous detection of HIV-1 and HCV in plasma samples.

MATERIALS AND METHODS:

A well-conserved region in the HIV-1 pol gene and 5'-NCR of HCV genome were used for primers and molecular beacon design. The performance features of HCV/HIV-1 multiplex NASBA assay including analytical sensitivity and specificity, clinical sensitivity and clinical specificity were evaluated.

RESULTS:

The analysis of scalar concentrations of the samples indicated that the limit of quantification of the assay was <1000 copies/ml for HIV-1 and <500 copies/ml for HCV with 95% confidence interval. Multiplex NASBA assay showed a 98% sensitivity and 100% specificity. The analytical specificity study with BLAST software demonstrated that the primers do not attach to any other sequences except for that of HIV-1 or HCV. The primers and molecular beacon probes detected all HCV genotypes and all major variants of HIV-1.

CONCLUSION:

This method may represent a relatively inexpensive isothermal method for detection of HIV-1/HCV co-infection in monitoring of patients.

KEYWORDS:

HCV; HIV-1; Molecular beacon; Multiplex NASBA assay

PMID:
22973469
PMCID:
PMC3434641
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center